Products Decitabine + Decitabine
Decitabine + Decitabine Phase 2 Terminated ⚡ Active Pediatric Acute Myelogenous Leukemia (AML)
Pediatric Acute Myelogenous Leukemia (AML)
Mar 3, 2011 → Jul 19, 2013
About Decitabine + Decitabine Decitabine + Decitabine is a phase 2 stage product being developed by Eisai for Pediatric Acute Myelogenous Leukemia (AML). The current trial status is terminated. This product is registered under clinical trial identifier NCT01177540. Target conditions include Pediatric Acute Myelogenous Leukemia (AML).
Clinical Trials (2) NCT ID Phase Status Start Completion Indication NCT01177540 Phase 2 Terminated Mar 3, 2011 Jul 19, 2013 Pediatric Acute Myelogenous Leukemia (AML) NCT00619099 Phase 2 Completed May 1, 2008 — Myelodysplastic Syndrome
Competing Products 20 competing products in Pediatric Acute Myelogenous Leukemia (AML)
See all competitors Product Company Stage Hype Score Ramucirumab Eli Lilly Phase 1 erlotinib + etoposide Astellas Pharma Phase 2 Mitoxantrone Hydrochloride Liposome + Irinotecan + Vincristine Sun Pharmaceutical Phase 1 Perampanel Oral Suspension + Perampanel Tablet Eisai Phase 2 Eribulin Mesylate Eisai Phase 1 Dasotraline 1 mg, 2 mg, 4 mg, 8 mg, 12 mg, 16 mg, 20 mg, 24 mg, 28 mg, 32 mg once daily Sumitomo Pharma Phase 1 Remimazolam Tosilate for injection + Propofol Injection Jiangsu Hengrui Medicine Phase 2/3 Ceftaroline fosamil + Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam + Cephalexin or Clindamycin or Linezolid AstraZeneca Phase 2/3 candsartan cilexetil AstraZeneca Phase 3 Durvalumab / Tremelimumab Combination Therapy AstraZeneca Phase 1/2 Rotavirus Vaccine Merck Pre-clinical basiliximab, MMF(mycophenolate mofetil), cyclosporine, prednisone (or equivalent) + MMF, cyclosporine, steroids Novartis Phase 3 VAL489 + VAL489 matching placebo Novartis Phase 3 LCZ696 + Enalapril + Placebo of LCZ696 + Placebo of Enalapril + LCZ696 Novartis Phase 2/3 Everolimus Novartis Phase 2 Corticosteroids + Cyclosporine + mycophenolate mofetil Roche Phase 2 Entecavir + Lamivudine + Pegylated Interferon Alfa-2A Roche Phase 3 Blinatumomab for Injection Amgen Phase 1 Etanercept Amgen Phase 3 Denosumab Amgen Phase 3
Other Products from Eisai